Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adjunct, alliance, Alongside, Army, baseline, Bhisitkul, bioavailable, Boalt, borrowing, cast, CGM, club, Coif, condensed, corrected, counteract, dangerously, disruption, disruptive, distancing, dosage, doubled, dozen, duration, Eastern, economy, effector, Eiger, endothelial, enzyme, explicit, faster, fat, Fauchet, float, fractional, furlough, gave, geographic, GlaxoSmithKline, globe, goal, Hall, Head, hereof, hospital, hybrid, ideally, immaterial, implicit, imposition, incorrectly, inflammation, insignificant, InterVest, intravenously, ISU, JMP, Joint, knockout, laser, leadership, led, length, lifted, Lim, liver, longest, mandated, marked, middle, murine, muscle, NDA, nearest, Nonrefundable, Olefsky, outbreak, package, pancreatic, pandemic, pause, paused, people, Philippe, physical, preliminary, proceed, prolonged, promptly, proportionate, protocol, reclassification, recommence, relaxed, repay, rescinded, residual, retroactively, RIZE, robustly, rodent, ROU, RPD, RRA, RZLTD, Secretary, Seoul, sharp, shelter, shipping, Silicon, situation, software, spread, stability, surfaced, surgery, tenure, territory, timeframe, timetable, tissue, Tokyo, transport, trust, UK, undertaken, unfavorable, unrelated, untreated, vi, voucher, wealth, Wuhan, Yonsei
Removed:
accelerate, add, adherence, agent, applied, Basaglar, basal, bimonthly, biosimilar, branded, burden, buyer, calculate, clearing, compelling, complying, concurrently, curb, David, death, deem, deposit, difficulty, dollar, Eli, Europe, expanding, explore, exposed, holder, Hoon, Hoyoung, Huh, impaired, implement, implementing, improvement, injectable, injection, lax, Levemir, Lilly, liquidate, liquidation, lowering, main, managed, mandatory, microsphere, month, Nordisk, Novo, Patel, PEGylated, permeability, pose, prandial, prepare, progressed, promissory, provisional, rata, recombinant, recording, recurring, regimen, regular, relation, release, reorganization, route, royalty, RVP, Samir, Sanofi, shareholder, specifically, Tae, tender, tolerability, Toujeo, tracking, Tresiba, uniform, upfront, Wall, Welch, yield
Filing tables
Filing exhibits
RZLT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Rezolute, Inc.’s Registration Statements on Form S-1 (File Nos. 333-234766, 333-233310, 333-222768, 333-220585, 333-214974, 333-204434, and 333-196093) of our report dated October 13, 2020 with respect to the consolidated financial statements of Rezolute, Inc. and subsidiary as of and for the years ended June 30, 2020 and 2019, that appears in this Annual Report on Form 10-K.
/s/ Plante & Moran, PLLC
October 13, 2020
Denver, Colorado